Vincent Theodore DeVita Jr. is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center, and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. He has been president of the American Cancer Society (2012-2013). He is internationally recognized as a pioneer in the field of oncology for his work on combination-chemotherapy treatments.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center and a New York State public-benefit corporation located in Buffalo, New York and founded by Roswell Park. Candace S. Johnson is President & Chief Executive Officer of Roswell Park Comprehensive Cancer Center. In 2018, Roswell Park ranked #30 on U.S. News & World Report's list of the best cancer hospitals in the country. Roswell Park was the first dedicated medical facility for cancer treatment and research in the United States, and is the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center." Roswell Park Comprehensive Cancer Center, which conducts clinical research on cancer as well as developing new drugs, provides advanced treatment for all forms of adult and pediatric cancer and serves as a member of the National Comprehensive Cancer Network.
The Children’s Oncology Group (COG), a clinical trials group supported by the National Cancer Institute (NCI), is the world’s largest organization devoted exclusively to pediatric cancer research. The COG conducts a spectrum of clinical research and translational research trials for infants, children, adolescents, and young adults with cancer.
Baylor Scott & White Medical Center – Temple is a 636-bed multi-specialty teaching hospital located in Temple, Texas. The facility was founded in 1897, when Dr. Arthur C. Scott and Dr. Raleigh R. White, Jr., opened the Temple Sanitarium in Temple, Texas. The group practice consists of over 800 physicians and scientists. The primary clinical teaching campus of Texas A&M Health Science Center College of Medicine, Baylor Scott & White – Temple is ranked as one of the top 100 hospitals and one of the top 15 teaching hospitals in the United States by Thomson Reuters. Baylor Scott & White – Temple has 31 accredited residency and fellowship programs, including programs in emergency medicine, radiology and offers a well-established and respected chaplain resident program.
Ralph David Feigin was an American pediatrician whose influential book Textbook of Pediatric Infectious Diseases was in its sixth printing at the time of his death.
David Agus is an American physician and author. He is a Professor of Medicine and Engineering at the University of Southern California. He is co-founder of Navigenics, a personalized medicine company and Applied Proteomics, as well as a CBS News contributor.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and Co-Director, Johns Hopkins Clinical Research Network.
Larry Kwak is an American cancer researcher who works at City of Hope in Duarte, California and is the Director of the Toni Stephenson Lymphoma Center at City of Hope. Dr. Kwak formerly worked at the University of Texas MD Anderson Cancer Center. He was included on Time's list of 2010's most influential people.
Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.
Professor Minesh P Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.
Frank Aram Oski was an American pediatrician. After holding several faculty positions at medical schools, he spent several years as the chair of pediatrics at Johns Hopkins School of Medicine. He was the founder and editor of the journal Contemporary Pediatrics, and he edited one of the most widely read textbooks in pediatrics.
Douglas R. Lowy is the Acting Director of the U.S. National Cancer Institute (NCI) and Chief of the Laboratory of Cellular Oncology within the Center for Cancer Research at NCI. Lowy previously served as Acting Director of NCI between April 2015-October 2017. On April 8, 2019, he again became Acting Director as Director Norman Sharpless transitioned to serve as the Acting Commissioner of the U.S. Food and Drug Administration. Lowy served as Deputy Director of the NCI since 2015, alongside former directors Harold E. Varmus and Sharpless. Lowy was co-recipient of the National Medal of Technology and Innovation in 2014 and the Lasker-DeBakey Clinical Medical Research Award in 2017.
Perry Nisen, M.D., Ph.D., is an American physician who is the former Chief Executive Officer (CEO) of the Sanford Burnham Prebys Medical Discovery Institute(SBP). He was appointed as CEO in August 2014, and held the Donald Bren Chief Executive Chair.
Arnold B. Rabson is an American scientist and biomedical researcher. He is the director of the Child Health Institute of New Jersey and the Laura Gallagher Chair of Developmental Biology at Robert Wood Johnson Medical School. Rabson is a Fellow of the American Association for the Advancement of Science.
Oliver Sartor is an American oncologist and research scientist. He is currently the Assistant Dean for Oncology and the C.E. and Bernadine Laborde Professor of Cancer Research, Medicine and Urology Departments at the Tulane School of Medicine in New Orleans, Louisiana. His research has mainly focused on translational science and clinical research trials of advanced prostate cancer since 1990 and he is recognized as an expert in that field through his contributions to the practice and the publishing of over 300 peer-reviewed articles and numerous Book Chapters and Reviews. Sartor also serves as the Editor-In-Chief of the bimonthly journal of Clinical Genitourinary Cancer that mainly focuses on research in genitourinary oncology.
Philip A. Pizzo, MD is an American professor, physician, and scientist. He is the David and Susan Heckerman Professor of Microbiology and Immunology at Stanford University, and founding director of Stanford's Distinguished Careers Institute. He served as the 11th Dean of the Stanford University School of Medicine from 2001 to 2012. He spent over two decades at the National Institutes of Health, and has devoted much of his medical career to the diagnosis, management, prevention and treatment of children with cancer and AIDS. He has also focused on the future of higher education, specifically for individuals in mid- to late-life.
Brigid Gray Leventhal was a British-American pediatric oncologist. She was the first director of the Pediatric Oncology Division at Johns Hopkins University, a position she held from 1976 to 1984. She was inducted into the Maryland Women's Hall of Fame in 1996.
